Donor-transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: A rare indication for liver retransplantation

Liver Transplantation

Volumn 14, Issue 2, 2008, Pages 155-158

  Snape, Katie ^a   Izatt, Louise ^a   Ross, Paul ^a   Ellis, David ^a   Mann, Kathy ^a   O'Grady, John ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TACROLIMUS;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CADAVER DONOR; CASE REPORT; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FLUORESCENCE ANALYSIS; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECURRENT DISEASE; REOPERATION; TREATMENT INDICATION;

ADENOCARCINOMA; FLUORESCENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HEPATITIS C; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; REOPERATION; TREATMENT OUTCOME;

EID: 39449102424     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21347     Document Type: Article

References (22)

1. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 2002;74:1409-1413.
2. Myron Kauffman H, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: donor related malignancies. Transplantation 2002;74:358-362.
3. Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000;70:232-236.
4. Baquero A, Foote J, Kottle S, Raja R, Mendez M, Noumoff J, et al. Inadvertent transplantation of choriocarcinoma into four recipients. Transplant Proc 1988;20:98.
5. Donovan JA, Simmons FA, Esrason KT, Jamehdor M, Busuttil RW, Novak JM, et al. Donor origin of a post transplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation 1997;63:80-84.
6. Baehner R, Magrane G, Balassanian R, Chang C, Millward C, Wakil AE, et al. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Hum Pathol 2000;31:1425-1429.
7. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malig-nancy despite emergency liver retransplantation. Liver Transpl 2003;9:1102-1107.
8. Loh E, Couch FJ, Hendricksen C, Farid L, Kelly PF, Acker MA, et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997;277:133.
9. Gerstenkorn C, Thomusch O. Transmission of a pancreatic adenocarcinoma to a renal transplant recipient. Clin Transplant 2003; 17:473-476.
10. Florman S, Bowne W, Kim-Schluger L, Sung MW, Huang R, Fotino M, et al. Unresectable squamous cell carcinoma of donor origin treated with immurrosuppression with-drawalandliverretransplantation. AmJTransplant2004:4: 278-282.
11. Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K Thibodeau SN. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 2002;33:435-436.
12. Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation 2003;76:871-873.
13. Cankovic M, Linden MD, Zarbo RJ. Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med 2006; 130:529-532.
14. Chan SC, Cheung ST, Leung SY, Liu CL, Fan ST, Lo CM. De novo sarcoma of donor origin in a liver allograft determined by microsatellite analysis: a short report. Liver Transpl 2004; 10:320-323.
15. Pfeiffer H, Ortmann C, Klein A, Brinkmann B. Origin of hepatocellular carcinoma recurring after allotransplantation revealed by microsatellite analysis. J Clin Pathol 1997;50:792-794.
16. Gomez-Roman JJ, Del Valle CE, Zarrabeitia MT, Martinez JC, Goni FZ, Lera RM, et al. Recurrence of bronchioloal-veolar carcinoma in donor lung after lung transplantation: microsatellite analysis demonstrates a recipient origin. Pathol Int 2005;55:580-584.
17. Mann K, Donaghue C, Fox SP, Docherty Z, Ogilvie CM. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet 2004; 12:907-915.
18. McPhaul JJ, McKintosh DA. Tissue transplantation still vexes. New Engl J Med 1965;272:105
19. Otero J, Fresno MF, Escudero D, Seco M, Gonzalez M, Peces R. Detection of occult disease in tissue donors by routine autopsy. Transpl Int 1998; 11: 152-154.
20. Morris-Stiff G, Steel A, Savage P, Devlin J, Griffiths D, Portman B, et al., for the Welsh Transplantation Research Group. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004;4:444-446.
21. Detry O, Honore P, Jacquet N, Meurisse M. Management of recipients of hepatic allografts harvested from donors with malignancy diagnosed shortly after transplantation. Clin Transplant 1998;12:579-581.
22. Kauffman HM, McBride MA, Delmonico FL. UNOS Transplant Tumor Registry: donors with a history of cancer. Transplant Proc 2001;33:1844-1845.